Correction: Balancing innovation and affordability in relapsing-remitting multiple sclerosis: a budget impact analysis from Saudi Arabia
Ahmed Al-Jedai, Hajer Almudaiheem, Faisal A. Al-Suweidan, Mohammed Al Jumah, Ahmed al-Thobaiti, Fahad Alzureiqan, Wejdan Abu Ras, Fahad M. Al-Dosari, Yaser Al Malik, Pratik Dhopte, Rita Ojeil
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMultiple Sclerosis Research Studies · Vaccine Coverage and Hesitancy · Health Systems, Economic Evaluations, Quality of Life
Affiliation ^3^Division of Neurology, Department of Medicine, Security Forces Hospital, Riyadh, Saudi Arabia was erroneously given as ^3^Critical Care Medicine, Security Forces Hospital, Riyadh, Saudi Arabia.
The original version of this article has been updated.